Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatmen
– Orca-T, Orca Bio’s lead investigational high-precision cell therapy, showed similar results in older patients undergoing myeloablative conditioning as seen in younger patients across disease control, non-relapse mortality and overall survival –– Orca-T in older patients given a reduced intensity conditioning regim...
Source: pharmiweb.com
